What is Cagent Vascular worth?
$80.7Mlast known valuation
Cagent Vascular last raised $24.5M in its Early Stage VC (May 2026).
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Cagent Vascular
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2026 | Early Stage VC | $24.5M | ▮ | ▮ |
| Jan 2024 | Early Stage VC | $28.7M | ▮ | ▮ |
| Apr 2023 | Debt | $7.2M | ▮ | ▮ |
| Jun 2021 | Early Stage VC | $9.5M | ▮ | ▮ |
| Jul 2017 | Seed Round | $3.0M | ▮ | ▮ |
How Cagent Vascular's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Cagent Vascular, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Cagent Vascular worth?
- Cagent Vascular's last known valuation is $80.7M.
- How much has Cagent Vascular raised?
- Cagent Vascular has raised $73.2M in total funding across 5 recorded rounds.
- When did Cagent Vascular last raise?
- Cagent Vascular last raised in May 2026 (Early Stage VC), raising $24.5M.